🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our NMD Scientists will be presenting four posters on our skeletal muscle specific chloride ion channel (ClC-1) inhibitors at the upcoming Muscular Dystrophy Association Muscular Dystrophy Association Clinical & Scientific Conference in Dallas, Texas, USA from 16-19 March. Jeanette Jeppesen Morgen,

Today is #IWD2025, a day to celebrate the value that women bring to our business and the wider #biotech community, as well as recognise the importance of #diversity and #inclusion. As we continue to pursue our vision, a future in which patients with #NeuromuscularDisease live

NMD Pharma is pleased to be sponsoring another @Cure SMA Summit of Strength meeting in Philadelphia, on 15 March. The meeting will bring together local and national experts who have experience of spinal muscular atrophy (#SMA) as we continue to progress, NMD670, our

We are excited to be participating in @Synapse DK – Life Science Connect’s half-day event at INCUBA Skejby, Aarhus, taking place on 20 March. This event will provide #LifesSciences students with the chance to connect with industry professionals from innovative companies, expand

From 30 March-1 April, Dan Brennan, SVP, Corporate and Commercial Strategy, and Vera Kiyasova, Director of Clinical Development, will be in Phoenix, AZ for the Myasthenia Gravis Foundation of America (#MGFA) 2025 National Patient Conference. This #conference brings together all members of the myasthenia

As we continue to advance our pipeline into late-stage development, we are looking to hire an Associate Director, Biostatistician, who will play a key role in shaping our #ClinicalDevelopment programs, ensuring robust statistical methodologies and supporting regulatory

We recently had the opportunity to present clinical and preclinical data on our novel, orally bioavailable skeletal muscle specific ClC-1 inhibitor at the Muscular Dystrophy Association Clinical & Scientific Conference, held last week in Dallas, TX. Included among these was an oral #presentation by

Our CEO, Thomas Holm Pedersen, will be presenting at the 9thAnnual Nordic-American Healthcare #Conference in New York City on 27 March at 11:00 AM ET. Join us as Thomas provides insight into our novel therapies with the potential to enable those living with neuromuscular

At NMD Pharma, we are Passionate About Movement and working together with the patient communities we serve. Join us at Myasthenia Gravis Foundation of America (#MGFA) 2025 National Patient Conference, where we will conduct two demonstration sessions from our “Breath. Move. Thrive. Yoga for Everybody.”

Are you ready to help build the IT capabilities within a growing biotech company? We are looking for an experienced IT Administrator to join our team in Aarhus, Denmark in a dual-focused role where you'll provide daily IT support while also driving development projects that will

At NMD Pharma, we believe that #CareerGrowth is a shared success and are committed to fostering an environment where everyone can develop and thrive. We’re thrilled to share that the following team members have been promoted: Pernille Bogetofte Thomasen, Senior Scientist,

NMD Pharma is a proud member of the thriving Danish and European biotech industry and was recently invited to participate in a historic Danish State visit to France, accompanying the HM The King and HM The Queen of Denmark as part of a Danish business delegation. Strategic

We’re thrilled to have Hang Nielsen and Michael Lundov joining the NMD Pharma team, further strengthening our regulatory expertise! Hang Nielsen, our new Senior Associate of Regulatory Affairs, joins us with a strong background in regulatory strategy and affairs, having

Our CEO, Thomas Holm Pedersen , will be giving the keynote speech at the upcoming #CMT #ClinicalTrial Readiness Summit, held from April 24-26 and organized by the HereditaryNeuropathy (HNF). Vera Kiyasova, Director of Clinical Development at #NMDPharma, will also be joining a panel,

NMD Pharma is #hiring! We are looking for an experienced Senior Medicinal Chemist to help advance our small molecule drug discovery programs towards the clinic. Key responsibilities for the role include: · Use on-target, off-target and ADME SAR data to design new compounds for

NMD Pharma is #hiring! We are looking for an experienced Clinical Pharmacology Scientist, based in Aarhus/Copenhagen, Denmark or remote (Europe/US), to help develop our innovative drug candidates from early development phase through to late-stage clinical trials. Key

Representatives from #NMDPharma will be giving a Company #presentation at the Aarhus Universitet PhD Career Day, held on 1 May. This annual event enables PhD students and postdocs to learn more about #career options in the #LifeSciences industry, and we look forward to meeting these

Today marks 10 incredible years since #NMDPharma was founded with a singular mission: to develop novel treatments for patients suffering from #neuromuscular disorders. What a journey it's been, from our early research on ClC-1 inhibition to watching NMD670 progress through

In recognition of our 10-year anniversary the NMD Pharma team have been celebrating and reflecting on our progress throughout the day 🎈🎉 We are incredibly proud to have built up a leading position in the development of novel and improved treatments for patients living with

NMD Pharma will be in The Hague, Netherlands from 13-15 May to attend and present at the 15th Myasthenia Gravis Foundation of America (MGFA) International Conference on Myasthenia and Related Disorders. With over 240 scientific presentations covering a variety of topics in the field of myasthenia